These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37376480)

  • 1. A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults.
    Beaty S; Collins N; Karasavvas N; Kuschner R; Hang J; Adhikari A; Maljkovic Berry I; Fung C; Walls S; Betancourt E; Mendy J; Lock M; Gierman E; Bennett S; Shabram P; Warfield K
    Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors.
    Weaver EA
    Hum Vaccin Immunother; 2014; 10(3):544-56. PubMed ID: 24280656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults.
    Lyons A; Longfield J; Kuschner R; Straight T; Binn L; Seriwatana J; Reitstetter R; Froh IB; Craft D; McNabb K; Russell K; Metzgar D; Liss A; Sun X; Towle A; Sun W
    Vaccine; 2008 Jun; 26(23):2890-8. PubMed ID: 18448211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Cycle Adenovirus Type 7 Vaccine for Prevention of Acute Respiratory Disease.
    Bullard BL; Corder BN; Weaver EA
    Viruses; 2019 May; 11(5):. PubMed ID: 31058858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines.
    Radin JM; Hawksworth AW; Blair PJ; Faix DJ; Raman R; Russell KL; Gray GC
    Clin Infect Dis; 2014 Oct; 59(7):962-8. PubMed ID: 24991024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.
    Mason BB; Davis AR; Bhat BM; Chengalvala M; Lubeck MD; Zandle G; Kostek B; Cholodofsky S; Dheer S; Molnar-Kimber K
    Virology; 1990 Aug; 177(2):452-61. PubMed ID: 2371766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment].
    Zhou J; Qu J; Shi C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits.
    Kuschner RA; Russell KL; Abuja M; Bauer KM; Faix DJ; Hait H; Henrick J; Jacobs M; Liss A; Lynch JA; Liu Q; Lyons AG; Malik M; Moon JE; Stubbs J; Sun W; Tang D; Towle AC; Walsh DS; Wilkerson D;
    Vaccine; 2013 Jun; 31(28):2963-71. PubMed ID: 23623865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial.
    Platt H; Omole T; Cardona J; Fraser NJ; Mularski RA; Andrews C; Daboul N; Gallagher N; Sapre A; Li J; Polis A; Fernsler D; Tamms G; Xu W; Murphy R; Skinner J; Joyce J; Musey L
    Lancet Infect Dis; 2023 Feb; 23(2):233-246. PubMed ID: 36116461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults.
    Blasiole DA; Metzgar D; Daum LT; Ryan MA; Wu J; Wills C; Le CT; Freed NE; Hansen CJ; Gray GC; Russell KL
    J Clin Microbiol; 2004 Apr; 42(4):1686-93. PubMed ID: 15071026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR.
    Houng HS; Liang S; Chen CM; Keith J; Echavarria M; Sanchez JL; Kolavic SA; Vaughn DW; Binn LN
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):227-36. PubMed ID: 12007439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
    Kibuuka H; Berkowitz NM; Millard M; Enama ME; Tindikahwa A; Sekiziyivu AB; Costner P; Sitar S; Glover D; Hu Z; Joshi G; Stanley D; Kunchai M; Eller LA; Bailer RT; Koup RA; Nabel GJ; Mascola JR; Sullivan NJ; Graham BS; Roederer M; Michael NL; Robb ML; Ledgerwood JE;
    Lancet; 2015 Apr; 385(9977):1545-54. PubMed ID: 25540891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study.
    Gurwith M; Lock M; Taylor EM; Ishioka G; Alexander J; Mayall T; Ervin JE; Greenberg RN; Strout C; Treanor JJ; Webby R; Wright PF
    Lancet Infect Dis; 2013 Mar; 13(3):238-50. PubMed ID: 23369412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis in the E1 region of adenovirus type 4 DNA.
    Tokunaga O; Yaegashi T; Lowe J; Dobbs L; Padmanabhan R
    Virology; 1986 Dec; 155(2):418-33. PubMed ID: 2947381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a new human adenovirus type 4 (Ad4) genotype: identification of a novel inverted terminal repeated (ITR) sequence from majority of Ad4 isolates from US military recruits.
    Houng HS; Clavio S; Graham K; Kuschner R; Sun W; Russell KL; Binn LN
    J Clin Virol; 2006 Apr; 35(4):381-7. PubMed ID: 16406799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.